Navigation Links
Aton Pharma Announces the Appointment of Dr. Fred Eshelman to Management Board
Date:2/25/2008

LAWRENCEVILLE, N.J., Feb. 25 /PRNewswire/ -- Aton Pharma, Inc., a global specialty pharmaceutical company, announced today that Dr. Fred Eshelman has joined the management board of Aton's parent company, Princeton Pharma Holdings LLC. Dr. Eshelman is the founder, Vice Chairman and CEO of Pharmaceutical Product Development, Inc. (Nasdaq: PPDI), an international contract research organization. Aton is a wholly owned subsidiary of Princeton Pharma Holdings LLC.

"We are delighted that Dr. Eshelman has agreed to join Princeton Pharma Holdings' management board," said Michael G. Wells, Chief Executive Officer of Aton Pharma. "He is a rare individual -- both an accomplished entrepreneur and an accomplished scientist. He built a very successful enterprise from the ground up and his knowledge of product development is exceptional. His insights are going to provide tremendous value to Aton as we implement our strategic plan."

"Aton is a very interesting specialty pharmaceutical company with their focus on medically essential therapeutics and I'm impressed with the amount of progress they have made in a relatively short period of time," stated Dr. Eshelman. "I look forward to lending my experience and helping this company reach its goals."

Dr. Eshelman's expertise will be helpful as Aton continues to execute its product life cycle management strategy and expand its research program, which includes partnerships with a variety of thought leaders, major medical institutions and research organizations.

Dr. Eshelman's career has included positions as Senior Vice President of Development and Vice President of Clinical Operations for the former Glaxo, Inc., as well as various roles in drug development with other pharmaceutical c
'/>"/>

SOURCE Aton Pharma, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Strativa Pharmaceuticals, a Division of Par Pharmaceutical, Announces the Discontinuation of the Development Program for Pafuramidine
2. Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2007 Financial Results
3. AstraZeneca Response to February 21, 2008 Ruling In Re: Alabama Medicaid Pharmaceutical AWP Litigation - cv2005-219 - Circuit Court of Montgomery, Alabama
4. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Fourth Quarter and Year-End 2007 Financial Results on Monday, February 25, at 8:30 A.M. EST
5. Nycomed US Inc. Acquires Bradley Pharmaceuticals, Inc.
6. WuXi PharmaTech Schedules Fourth Quarter and Full Year 2007 Earnings Release on Wednesday, March 12, 2008
7. Genmab and PDL BioPharma Sign Purchase Agreement for Antibody Manufacturing Facility
8. Cadence Pharmaceuticals Completes $49.3 Million Registered Direct Offering
9. Addrenex Pharmaceuticals Reaches Milestone with Filing of NDA for First Product, CloniBID, to Treat Hypertension
10. Vion Pharmaceuticals to Implement a One-for-Ten Reverse Stock Split
11. Sunesis Pharmaceuticals Announces Milestone Payment from Inflammation Collaboration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2009)...ENIX, July 2 As many as five to ...h an eating disorder because they,re ashamed to ad...Programs for Eating and Anxiety Disorders . Healt...nds often are unaware of the high-risk behaviors i...fore, effective intervention is often not availabl...
(Date:7/1/2009)...ew statistical analysis technique that identifies ...ased artifacts from experimental data could lead t...erials and nanostructures likely to have future in...file adjustment by regression (SPAR), the techniqu...a required to make conclusions, and help distingui...
(Date:7/1/2009)...ority is collaborating effectively with government...in for delivering Pfizer-donated Zithromax , ,...ternational Trachoma Initiative (ITI) has a new le...orations among governments and NGOs in 56 trachoma... ITI hopes to support local, national, regional, a...
(Date:7/1/2009)...NE, Pa., July 1 Encoriu...ultinational contract research organization (CRO) ...capabilities for clinical trials and patient regis...l companies, today provided an update to the expec... letter of intent with Pierrel SpA, an internation...
Breaking Biology Technology:Remuda Ranch Programs for Eating and Anxiety Disorders Reports Need for Increasing Awareness of Eating Disorders in Males 2New statistical technique improves precision of nanotechnology data 2New statistical technique improves precision of nanotechnology data 3New statistical technique improves precision of nanotechnology data 4New Leadership Team at International Trachoma Initiative to Build Stronger Partnerships to Eliminate Blinding Trachoma 2Encorium Group Updates Expected Timeframe with Respect to the Sale of its U.S. Business 2Encorium Group Updates Expected Timeframe with Respect to the Sale of its U.S. Business 3Encorium Group Updates Expected Timeframe with Respect to the Sale of its U.S. Business 4
...al and Other Hard-to-transfect Cells , ... Kevin Kelnar, David Brown, Ambion, In...A interference (RNAi) is a powerful , ...on of specific , genes. It is u..., validation, and gene discovery...
...l RNAs such as transfer RNAs , ...s (snoRNA), , and small nuclear... variety of cellular processes, from regu...re-mRNA splicing or transcription to chromosome ,.... In addition, two novel , clas...
...s apparent specificity, , repro...eatly , accelerating the functi...ase-relevant genes for drug discovery, target vali...forts. To ensure the validity of RNAi , ... and controls are , needed. Thi...
... Cells, Blood, Bacteria and Yeast , ... array analysis have found that a combination of... RNA extraction methods often provide superior ,...one (1-3). Ambion,s new line , ...that combine , these RNA extrac...
Other Biology Technology:Delivering siRNAs to Difficult Cell Types 2Delivering siRNAs to Difficult Cell Types 3Delivering siRNAs to Difficult Cell Types 4Delivering siRNAs to Difficult Cell Types 5Delivering siRNAs to Difficult Cell Types 6Delivering siRNAs to Difficult Cell Types 7New Tools for Small RNA Analysis 2New Tools for Small RNA Analysis 3New Tools for Small RNA Analysis 4New Tools for Small RNA Analysis 5New Tools for Small RNA Analysis 6New Tools for Small RNA Analysis 7New Tools for Small RNA Analysis 8Designing Controls for siRNA , Experiments 2Designing Controls for siRNA , Experiments 3Designing Controls for siRNA , Experiments 4Designing Controls for siRNA , Experiments 5Improve RNA Isolation for Array Analysis and More 2Improve RNA Isolation for Array Analysis and More 3Improve RNA Isolation for Array Analysis and More 4Improve RNA Isolation for Array Analysis and More 5Improve RNA Isolation for Array Analysis and More 6
(Date:7/2/2009)...to study a group of proteins that are highly effec...key to developing new types of antibiotics. , Re...have been awarded 3.3m from the Biotechnology and ...nd out how a family of proteins known as colicins ...ying them. , The team, led by Professor Colin Kl...
(Date:7/1/2009)... including plague, Ebola and Rift Valley Fever are...nd international partnership involving African res...Centre (LIDC). The Southern African Centre for Inf...l and veterinary institutions from five African co...can institutions to detect, identify and monitor i...
(Date:7/1/2009)... work on the formation of the centromere, a key ce...osome segregation and accurate cell division, has ...nd a prestigious EMBO installation grant, of 50,00...Lars Jansen moved from California to the Instituto...r to head the Epigenetic Mechanisms group. The Na...
(Date:7/1/2009)...erican Dietetic Association has released an update...s such diets, if well-planned, are healthful and n...cents and can help prevent and treat chronic disea...iabetes. , ADA,s position, published in the July...sociation , represents the Association,s official ...
Breaking Biology News(10 mins):Research network wins approximately £5.7 million to target human and animal diseases in Africa 2Research network wins approximately £5.7 million to target human and animal diseases in Africa 3Double success for Instituto Gulbenkian de Ciencia scientists working on chromosome segregation 2ADA releases updated position paper on vegetarian diets 2EPA Presents Initial Results from Caliper Life Sciences ToxCast Screening Effort 11096 1EPA Presents Initial Results from Caliper Life Sciences ToxCast Screening Effort 11096 2EPA Presents Initial Results from Caliper Life Sciences ToxCast Screening Effort 11096 3EPA Presents Initial Results from Caliper Life Sciences ToxCast Screening Effort 11096 4Clean Spa Technologies USA Adopts GeniJet 28TM 29 Plus Hydrotherapy System with Built In Ionizer Sets Industry Standard for Pedicure Hygiene 40058 1Clean Spa Technologies USA Adopts GeniJet 28TM 29 Plus Hydrotherapy System with Built In Ionizer Sets Industry Standard for Pedicure Hygiene 40058 2Poniard Pharmaceuticals to Present at Needham 26 Companys Cancer Therapeutics 3A Today 26 Tomorrow Conference 40054 1Poniard Pharmaceuticals to Present at Needham 26 Companys Cancer Therapeutics 3A Today 26 Tomorrow Conference 40054 2Abaxis Inc to Attend Lazard Capital Markets Medical Technologies Conference 40050 1
...henomenon in which one bacterial cell can stop the...ia that stop growing may go into a dormant state, ...for management of chronic diseases, such as urinar...cientists working in the laboratory of David Low, ...ia, Santa Barbara, is reported in the August 19 is...
...patients reject their new organs requires a workin...eject each other. Xavier Fernndez-Busquets, an MBL...ona, has found the perfect ally in this quest: the...ows abundantly from just north of Cape Cod down to...rolifera) has a cell-to-cell recognition system th...
...free season in Alaska,s tundra, and a correspondin...d trees, may be creating a cycle of warmer and lon...ew study to be published in the Sept. 22, 2005, is...c heating in the region of northern Alaska is equi...ubling of carbon dioxide in the atmosphere. Contin...
...and their colleagues have their way, cheetahs, lio... may soon roam parts of North America. , "If we o...hink we,re nuts," said Harry Greene, professor of ...if people hear the one-hour version, they realize .... Right now, we are investing all of our megafauna...
Other Biology News:One bacteria stops another on contact 2Simple sea sponge helps scientists understand tissue rejection 2Lands surface change on Alaska tundra creating longer, warmer summers in Arctic 2Proposal would allow wild animals to roam North America 2Proposal would allow wild animals to roam North America 3
L-Selenomethionine from Calbiochem
Signets Xylene Resistant (X/R) Red System consists of concentrated X/R Red Chromogen, X/R Red Activator and X/R Red Buffer. The X/R Red solution reacts with alkaline phosphatase to produce red staini
Phospho-YAP (Ser127) Antibody Ship: Hot Store: -20 C
Mouse Cell Line Slides
Biology Products: